title: Myopathy secondary to simvastatin in a type 2 diabetic patient.
abstract: The most important but rare adverse effect of simvastatin is myopathy. In megatrials with simvastatin, the overall incidence of myopathy is 0.025%. We present a case of myopathy presenting as proximal muscle weakness in both upper limbs secondary to simvastatin which reversed spontaneously after cessation of the drug.
authors.affiliation: JLN Medical College and AG Hospitals, Ajmer.
authors.forename: H
authors.initials: H
authors.lastname: Udawat
authors.forename: R K
authors.initials: RK
authors.lastname: Goyal
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced* / Q000503:physiopathology; D019821:Simvastatin / Q000009:adverse effects*
chemical_list: D000924:Anticholesteremic Agents; D019821:Simvastatin